Product
MAGMA-trial: conventional chemotherapy (AraC+DNR)+Midostaurin
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
MidOStaurin + Gemtuzumab OzogAmIcin Combination in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)Status: Recruiting, Estimated PCD: 2027-04-01